Nothing explains the importance of looks, like the growth of the global cosmetic surgery market. From enhancing one’s confidence level, to be a major game changer in professional and social situations, cosmetic surgery is seen by many as that one magic element which can influence and bring in positive changes in life. Non-invasive surgeries along with facelift, breast augmentation, rhinoplasty, liposuction, tummy tuck, and laser treatments are some cosmetic processes which are quite high in demand. The cosmetic surgery market size will grow by USD 10.56 billion during 2019-2023. The report analyzes the market’s competitive landscape and offers information on several companies including ALLERGAN, Bausch Health, Galderma laboratories, Hologic Inc., and Merz Pharma.
Download the free sample report @ http://bit.ly/2lI87G8
A global pharmaceutical company, Allergan focuses on developing, manufacturing, and commercializing branded pharmaceuticals, devices, and biologic products for patients around the world. Based in Dublin, Ireland, Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology, and anti-infective therapeutic categories.
Allergan has established a strong brand image in the cosmetic surgery market with its flagship brands. It key brands include BOTOX Cosmetic and JUVÉDERM in the facial aesthetics category; Natrelle in the breast augmentation and construction category; and LATISSE in the other non-surgical cosmetic brands category.
2) Merz Pharma
Headquartered in Frankfurt, Germany, Merz Pharma specializes in OTC and prescription creams, ointments and injectables in the fields of dermatology, neurology, and metabolic disorders. Aesthetics and Neurotoxins are the two core businesses Merz has been consistently working on.
Merz Pharma has a broad product portfolio in the cosmetic surgery market. It manufactures and sells a wide range of products and solutions in the field of aesthetic medicine. It engages in the development and distribution of new products in the areas of aesthetic medicine and dermatology. Its key product offerings include Anteis, Belotero, RADIESSE, and ETERMIS; and Neurotoxins like Botulinum.
Get the Complete Report @ http://bit.ly/2lKiXv8
Galderma is a global dermatology company collaborating with healthcare professionals to provide innovative medical solutions to patients with skin health needs. The company has 35 wholly-owned affiliates and a worldwide network of distributors, and an extensive product portfolio available in more than 100 countries.
The company offers a wide range of products and solutions in the cosmetic surgery market with its well-established brands. Its key product offerings include Benzac for the treatment of acne; Calmurid and Cetaphil for the treatment of dry skin; Dysport for the treatment of glabellar lines; and Emervel for the treatment of facial lines, and for lip enhancement; Macrolane for body contouring; Restylane for skincare; and Tetralysal for the treatment of acne.
Cynosure is a leading developer and manufacturer of a broad array of light-based aesthetic and medical treatment systems. Their products are used to provide a diverse range of treatment applications such as body contouring, hair removal, skin rejuvenation and scar reduction, as well as the treatment of vascular lesions.
Through R&D, Cynosure’s business strategy is focused on launching new products and technologies, such as body contouring, for cosmetic applications. It also aims to expand its product offerings through acquisitions and significant partnerships. For instance, In September 2014, the company expanded its technology base by acquiring Ellman International, a provider of advanced radio frequency (RF) technology for precision surgical and aesthetic procedures that offers a broad line of aesthetic lasers; and in June 2013, the company acquired Palomar Medical Technologies, including its SlimLipo, which features fat melting laser wavelengths that gently liquefy fat.
5) Valeant Pharmaceuticals
Founded in 1960, the company develops, manufactures, and distributes a wide range of branded, generic pharmaceutical, OTC products, and medical devices. It specializes in dermatology, eye health, consumer health, and neurology. CeraVe, VASERlipo System, Obagi, and Liposonix, are some of its major product offerings.
In January 2016, Valeant Canada divested its aesthetics unit to Intega Skin Sciences, in which it acquired Valeant’s Groupe Cosméderme that includes Laboratoire Dr Renaud, Pro-Derm, and Premiology, and three high-end medical skincare brands.